3 Month PHI PAD PoM Study

Summary

This is a multi-center, randomized, blinded, placebo controlled study to evaluate the safety of GSK1278863 and its acute and short-term (e.g. 14d) effects on calf muscle endurance and walking ability in subjects with PAD and symptomatic claudication.

Timeline

Start

2010-10-15

Primary completion

2011-11-01

Completion

2011-11-01

Drugs

Indications